Kintor’s Dual c-Myc/GSPT1 Degradation Therapy GT19715 Shows Promise in Pre-Clinical Studies
China-based Kintor Pharmaceutical Ltd (HKG: 9939) has published positive results from a pre-clinical study of...
TPD
Accutar Biotechnology Initiates Phase I Trial for ERα Targeting Degradation Molecule AC0682
New Jersey-based Accutar Biotechnology Inc., which is heavily backed by Chinese funds, has announced the...
Gluetacs Therapeutics Files IND for Molecular Glue Degrading Agent in China
Gluetacs Therapeutics has reported filing an Investigational New Drug (IND) application for its first molecular...
U Protech Secures Angel Financing for PROTAC and Molecular Glue Drug Pipeline
U Protech, a Hangzhou-based biotech focused on next-generation protein degradation therapies, has raised tens of...
Ranok Therapeutics Doses First Patient in RNK05047 Study for BRD4-Targeted Cancers
Ranok Therapeutics Co., Ltd, a Hangzhou-based biotech firm, announced that the first patient has been...
Kintor Pharma Completes GT20029 Phase I Study for Hair Loss and Acne
China-based Kintor Pharmaceutical Ltd (HKG: 9939) announced the completion of dosing all 92 subjects in...
Coherent Biopharma Raises Series B Funds to Advance Bi-XDC Pipeline
Coherent Biopharma Ltd, a Suzhou-based specialist in bispecific-ligand drug conjugates (Bi-XDC), has reportedly raised an...
GluBio Pharma Raises USD 22M in Series A+ Round to Advance TPD Pipeline
GluBio Pharmaceutical Co., Ltd, a Zhejiang-based specialist in molecular glue targeted protein degradation (TPD), reportedly...
Attec Completes Pre-Series A Financing with Sequoia China Backing Protein Degradation Tech
China-based biotech startup Attec has completed a pre-Series A financing round, with its protein degradation...
InnoCare Pharma’s ICP-490 Receives NMPA Approval for Hematological Malignancies
Beijing InnoCare Pharma (HKG: 9969) announced that it has received clinical trial approval from the...
HealZen Therapeutics and Hisun Partner on First-in-Class Protein Degradation Product
Hangzhou-based HealZen Therapeutics Protein Degradation Hisun Pharmaceutical Co., Ltd. a has formed a strategic partnership...